Predicting binding modes of reversible peptide-based inhibitors of falcipain-2 consistent with structure-activity relationships

Proteins. 2017 Sep;85(9):1666-1683. doi: 10.1002/prot.25322. Epub 2017 Jun 7.

Abstract

Falcipain-2 (FP-2) is a major hemoglobinase of Plasmodium falciparum, considered an important drug target for the development of antimalarials. A previous study reported a novel series of 20 reversible peptide-based inhibitors of FP-2. However, the lack of tridimensional structures of the complexes hinders further optimization strategies to enhance the inhibitory activity of the compounds. Here we report the prediction of the binding modes of the aforementioned inhibitors to FP-2. A computational approach combining previous knowledge on the determinants of binding to the enzyme, docking, and postdocking refinement steps, is employed. The latter steps comprise molecular dynamics simulations and free energy calculations. Remarkably, this approach leads to the identification of near-native ligand conformations when applied to a validation set of protein-ligand structures. Overall, we proposed substrate-like binding modes of the studied compounds fulfilling the structural requirements for FP-2 binding and yielding free energy values that correlated well with the experimental data. Proteins 2017; 85:1666-1683. © 2017 Wiley Periodicals, Inc.

Keywords: MM-GBSA; accelerated molecular dynamics; binding free energy; binding mode; docking; falcipain-2; molecular dynamics; peptide-based inhibitors.

MeSH terms

  • Animals
  • Antimalarials / chemistry*
  • Antimalarials / therapeutic use
  • Cysteine Endopeptidases / chemistry*
  • Cysteine Endopeptidases / drug effects
  • Cysteine Endopeptidases / metabolism
  • Humans
  • Malaria, Falciparum / drug therapy*
  • Malaria, Falciparum / parasitology
  • Molecular Conformation
  • Molecular Docking Simulation
  • Molecular Dynamics Simulation
  • Peptides / chemistry*
  • Plasmodium falciparum / drug effects
  • Protein Binding
  • Structure-Activity Relationship

Substances

  • Antimalarials
  • Peptides
  • Cysteine Endopeptidases
  • falcipain 2